Faeth Therapeutics: Faeth Presents Updated Preclinical Data at ESMO, including First-Ever Head-to-Head Characterization of PIKTOR against Gedatolisib
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Fri, 23 October 2026
What it is about
Karen VousdenAnand ParikhMatthew BieglerSiddhartha MukherjeeOliver MaddocksPatrick SchmidtGreg HannonLewis CantleyScott LoweEuropean Society For Medical OncologyExxonmobilExchange CommissionChevronCompany Annual Report On FormNasdaqShellCompany On LinkedinMadrid, Madrid, SpainIranSpain
Who published it, and when
How it spread - 1 original report
Fri, 23 October 2026
1 report- finanznachrichten.de15:18first to report
In two preclinical breast cancer xenograft models (abstract #431P), PIKTOR inhibited tumor growth to a comparable or greater extent than intravenous gedatolisibPIKTOR inhibited HR+/HER2- breast cancer